News

2018

DATE

TITLE

September 28 ProtoKinetix Begins Cardiovascular Research
September 4 ProtoKinetix AAGP® Molecule Moving Forward in Key Healthcare Studies Targeting Important Health Care Solutions
August 10 ProtoKinetix Enters into 3rd Phase of Retinal Cell Replacement Therapy Testing at UBC
June 13 ProtoKinetix' AAGP® Signs a Material Transfer Agreement with a Reputed International Biotech Company
January 10 ProtoKinetix Has Entered into a Research Agreement with The University of British Columbia to Test the Effect of its AAGP™ on Monoclonal Antibody Production and Bone Marrow Recovery

 

2017

DATE

TITLE

November 16 The Effects of ProtoKinetix' Anti-Aging Glycopeptide (AAGP™) on Immune Cell Banking and Functions Relevant to Immunotherapy
October 17 Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery
June 5 ProtoKinetix and Proactive Immune Sciences Announce a Joint Research Collaboration Using AAGP™ in Immune Cell Cryopreservation Testing
May 24 ProtoKinetix Completes First Year of Trials on Retinal Replacement Therapy Using AAGP™
Mar 9 ProtoKinetix Announces Start of Phase 1 & Phase 2 Clinical Trials for the use of AAGP™ PKX-001 Treated Islet Cells in the Treatment of Type 1 Diabetes
Feb 7 ProtoKinetix Updates Testing Progress on Neuronal Retinal Cells in Living Tissue for the Treatment of Macular Degeneration
Jan 24 ProtoKinetix Announces Investigator Sponsored Human Clinical Trial Application Using AAGP™ Has Been Approved by Health Canada
Jan 17 ProtoKinetix, Incorporated Announces Investigator Sponsored Clinical Trial Submitted to Health Canada for the use of AAGP™ in the Treatment of Type 1 Diabetes
   

 

2016

DATE

TITLE

July 14 ProtoKinetix’ 2nd Quarter Scientific Update
June 16 ProtoKinetix Completes Non-Brokered Private Placement & Secures Operating Line of Credit
June 7 ProtoKinetix’ AAGP™ has been Published in the Journal of Tissue Engineering and Regenerative Medicine
May 12 ProtoKinetix Updates Progress Toward Clinical Trial Application for AAGP™
May 2 AAGP™ Improves Results in Stem Cells Transplanted in Retina Tissue by 300%
April 26 ProtoKinetix Outlines Steps to Clinical Trial Application for AAGP™